|
1
|
Martins SF, Garcia EA, Luz MA, Pardal F,
Rodrigues M and Filho AL: Clinicopathological correlation and
prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3
expression in colorectal cancer. Cancer Genomics Proteomics.
10:55–67. 2013.PubMed/NCBI
|
|
2
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Des Guetz G, Uzzan B, Nicolas P, Cucherat
M, Morere JF, Benamouzig R, Breau JL and Perret GY: Microvessel
density and VEGF expression are prognostic factors in colorectal
cancer. Meta-analysis of the literature. Br J Cancer. 94:1823–1832.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martins SF, Reis RM, Rodrigues AM,
Baltazar F and Filho AL: Role of endoglin and VEGF family
expression in colorectal cancer prognosis and anti-angiogenic
therapies. World J Clin Oncol. 2:272–280. 2011.PubMed/NCBI
|
|
5
|
Barderas R, Mendes M, Torres S, Bartolomé
RA, López-Lucendo M, Villar-Vázquez R, Peláez-García A, Fuente E,
Bonilla F and Casal JI: In-depth characterization of the secretome
of colorectal cancer metastatic cells identifies key proteins in
cell adhesion, migration, and invasion. Mol Cell Proteomics.
12:1602–1620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arlt F and Stein U: Colon cancer
metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem
Cell Biol. 41:2356–2359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Connell JB, Maggard MA and Ko CY: Colon
cancer survival rates with the new American Joint Committee on
Cancer sixth edition staging. J Natl Cancer Inst. 96:1420–1425.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murata K and Moriyama M: Isoleucine, an
essential amino acid, prevents liver metastases of colon cancer by
antiangiogenesis. Cancer Res. 67:3263–3268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iqbal S and Lenz HJ: Angiogenesis
inhibitors in the treatment of colorectal cancer. Semin Oncol.
31(Suppl 17): 10–16. 2004. View Article : Google Scholar
|
|
10
|
El Zouhairi M, Charabaty A and Pishvaian
MJ: Molecularly targeted therapy for metastatic colon cancer:
Proven treatments and promising new agents. Gastrointest Cancer
Res. 4:15–21. 2011.PubMed/NCBI
|
|
11
|
Mori R, Wang Q, Danenberg KD, Pinski JK
and Danenberg PV: Both beta-actin and GAPDH are useful reference
genes for normalization of quantitative RT-PCR in human FFPE tissue
samples of prostate cancer. Prostate. 68:1555–1560. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murthi P, Fitzpatrick E, Borg AJ, Donath
S, Brennecke SP and Kalionis B: GAPDH, 18S rRNA and YWHAZ are
suitable endogenous reference genes for relative gene expression
studies in placental tissues from human idiopathic fetal growth
restriction. Placenta. 29:798–801. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harada N, Yasunaga R, Higashimura Y,
Yamaji R, Fujimoto K, Moss J, Inui H and Nakano Y:
Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional
activity of androgen receptor in prostate cancer cells. J Biol
Chem. 282:22651–22661. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tisdale EJ: Glyceraldehyde-3-phosphate
dehydrogenase is required for vesicular transport in the early
secretory pathway. J Biol Chem. 276:2480–2486. 2001. View Article : Google Scholar
|
|
15
|
Sirover MA: On the functional diversity of
glyceraldehyde-3-phosphate dehydrogenase: Biochemical mechanisms
and regulatory control. Biochim Biophys Acta. 1810:741–751. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng L, Roeder RG and Luo Y: S phase
activation of the histone H2B promoter by OCA-S, a coactivator
complex that contains GAPDH as a key component. Cell. 114:255–266.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Epner DE, Partin AW, Schalken JA, Isaacs
JT and Coffey DS: Association of glyceraldehyde-3-phosphate
dehydrogenase expression with cell motility and metastatic
potential of rat prostatic adenocarcinoma. Cancer Res.
53:1995–1997. 1993.PubMed/NCBI
|
|
18
|
Tang Z, Yuan S, Hu Y, Zhang H, Wu W, Zeng
Z, Yang J, Yun J, Xu R and Huang P: Over-expression of GAPDH in
human colorectal carcinoma as a preferred target of 3-bromopyruvate
propyl ester. J Bioenerg Biomembr. 44:117–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sirover MA: New nuclear functions of the
glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in
mammalian cells. J Cell Biochem. 95:45–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peña C, García JM, Silva J, García V,
Rodríguez R, Alonso I, Millán I, Salas C, de Herreros AG, Muñoz A,
et al: E-cadherin and vitamin D receptor regulation by SNAIL and
ZEB1 in colon cancer: Clinicopathological correlations. Hum Mol
Genet. 14:3361–3370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barberà MJ, Puig I, Domínguez D,
Julien-Grille S, Guaita-Esteruelas S, Peiró S, Baulida J, Francí C,
Dedhar S, Larue L, et al: Regulation of Snail transcription during
epithelial to mesenchymal transition of tumor cells. Oncogene.
23:7345–7354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tokunaga K, Nakamura Y, Sakata K, Fujimori
K, Ohkubo M, Sawada K and Sakiyama S: Enhanced expression of a
glyceraldehyde-3-phosphate dehydrogenase gene in human lung
cancers. Cancer Res. 47:5616–5619. 1987.PubMed/NCBI
|
|
26
|
Révillion F, Pawlowski V, Hornez L and
Peyrat JP: Glyceraldehyde-3-phosphate dehydrogenase gene expression
in human breast cancer. Eur J Cancer. 36:1038–1042. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Puzone R, Savarino G, Salvi S, Dal Bello
MG, Barletta G, Genova C, Rijavec E, Sini C, Esposito AI, Ratto GB,
et al: Glyceraldehyde-3-phosphate dehydrogenase gene over
expression correlates with poor prognosis in non small cell lung
cancer patients. Mol Cancer. 12:972013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nguyen DX and Massagué J: Genetic
determinants of cancer metastasis. Nat Rev Genet. 8:341–352. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beerling E, Seinstra D, de Wit E, Kester
L, van der Velden D, Maynard C, Schäfer R, van Diest P, Voest E,
van Oudenaarden A, et al: Plasticity between epithelial and
mesenchymal states unlinks EMT from metastasis-enhancing stem cell
capacity. Cell Rep. 14:2281–2288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Higashimura Y, Nakajima Y, Yamaji R,
Harada N, Shibasaki F, Nakano Y and Inui H: Up-regulation of
glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1
activity depending on Sp1 in hypoxic breast cancer cells. Arch
Biochem Biophys. 509:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan F, Samuel S, Evans KW, Lu J, Xia L,
Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA, et al: Overexpression of
snail induces epithelial-mesenchymal transition and a cancer stem
cell-like phenotype in human colorectal cancer cells. Cancer Med.
1:5–16. 2012. View
Article : Google Scholar
|
|
32
|
Han X, Fang X, Lou X, Hua D, Ding W, Foltz
G, Hood L, Yuan Y and Lin B: Silencing SOX2 induced
mesenchymal-epithelial transition and its expression predicts liver
and lymph node metastasis of CRC patients. PLoS One. 7:e413352012.
View Article : Google Scholar : PubMed/NCBI
|
